[Vasoprotective effect of effective lipid-lowering therapy in patients with


Journal

Terapevticheskii arkhiv
ISSN: 0040-3660
Titre abrégé: Ter Arkh
Pays: Russia (Federation)
ID NLM: 2984818R

Informations de publication

Date de publication:
16 Jan 2023
Historique:
received: 07 08 2021
medline: 15 5 2023
pubmed: 11 5 2023
entrez: 11 5 2023
Statut: epublish

Résumé

To study the vasoprotective effects of atorvastatin depending on the achievement of the target level of low-density lipoprotein cholesterol (LDL-C) in patients with Included were 112 When examining the carotid arteries in the HET group, the intima-media thickness (IMT) decreased by 10.7-13.1%, the b index - by 14.9-26.3% after 24-48 weeks. In the RET group, the IMT regression was 10.4-13.3%; b index - 23.9% by the 48th week. In the IET group, the b index decreased by the 48th week by 14.3%. According to applanation tonometry in the HET group, the central pressure did not change. In the RET group, systolic pressure in the aorta increased by 10-15.7% after 24-48 weeks, pulse pressure - by 33.9% by the end of observation. With IET, the increase was 8.6-6.8 and 19.8-25.9%, respectively. The odds ratio of developing endpoints in the RET group was 4.7 (95% CI 1.2-26.4; The most pronounced vasoprotective effect and a decrease in cardiovascular risk are associated with the achievement of the target LDL-C throughout the entire treatment period. Цель. Изучить вазопротективные эффекты аторвастатина в зависимости от достижения целевого уровня холестерина липопротеидов низкой плотности (ХС ЛНП) у больных с инфарктом миокарда с подъемом сегмента

Autres résumés

Type: Publisher (rus)
Цель. Изучить вазопротективные эффекты аторвастатина в зависимости от достижения целевого уровня холестерина липопротеидов низкой плотности (ХС ЛНП) у больных с инфарктом миокарда с подъемом сегмента

Identifiants

pubmed: 37167178
doi: 10.26442/00403660.2022.12.202007
doi:

Substances chimiques

Atorvastatin A0JWA85V8F
Cholesterol, LDL 0

Types de publication

English Abstract Journal Article

Langues

rus

Sous-ensembles de citation

IM

Pagination

1355-1360

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH